Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

MRI contrast agents from Nycomed Salutar

Nov. 1, 1996

Antiobesity proteins described by Lilly

Nov. 1, 1996

Canadian researchers claim hPTH analogues for osteoporosis

Nov. 1, 1996

Lilly continues to investigate new agents for women's health

Nov. 1, 1996

Low-toxicity antitumor agents described by Ajinomoto

Nov. 1, 1996

Antitumor organotin compounds claimed by Dutch company

Nov. 1, 1996

Cell adhesion inhibitors reported by Sumitomo

Nov. 1, 1996

HHS claims MAb for therapeutic, diagnostic and immunologic applications

Nov. 1, 1996

Antitumor antibody for medulloblastoma Rx claimed by Chugai

Nov. 1, 1996

Polyamine antimetabolites claimed by Ciba-Geigy

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...